Drug Profile
Research programme: DNA- and RNA-based toll-like receptor agonists - Aceragen
Alternative Names: HYB-2048; HYB-2093; IMO-4200Latest Information Update: 20 Jan 2023
Price :
$50
*
At a glance
- Originator Idera Pharmaceuticals
- Developer Aceragen
- Class Oligonucleotides
- Mechanism of Action Toll-like receptor 3 agonists; Toll-like receptor 7 agonists; Toll-like receptor 8 agonists; Toll-like receptor 9 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Allergic asthma; Cancer; Haematological malignancies; Viral infections